Milad Riazifar

Dr. Milad Riazifar is a Scientist at City of Hope, specializing in Translational Sciences and Cellular Therapeutics. He is actively involved in a clinical trial aimed at effectively treating type I Diabetes patients by utilizing exosomes.

Dr. Riazifar pursued his academic journey by earning a Doctor of Philosophy (PhD) degree in Pharmacological Sciences from the University of California, Irvine. His educational background is a testament to his expertise and dedication to the field.

Throughout his career, Dr. Riazifar has held key roles in various prestigious organizations. He currently serves as a Scientist in the Department of Cellular Therapeutics at City of Hope, showcasing his commitment to cutting-edge research and innovation.

Prior to his current role, Dr. Riazifar gained valuable experience as an Intern in Therapeutic Discovery at Amgen, further honing his skills and knowledge in the pharmaceutical industry. Additionally, he has served as a Ph.D. Candidate and Research Associate at UC Irvine, solidifying his foundation in academia and research.

Dr. Riazifar's passion for advancing healthcare solutions and his extensive experience in translational sciences make him a valuable asset in the quest for groundbreaking treatments and therapies.

His dedication to improving patient outcomes and his active involvement in clinical trials highlight his unwavering commitment to making a positive impact in the field of cellular therapeutics.